Identification of Alcohol Use Prior to Major Cancer Surgery: Timeline Follow Back Interview Compared to Four Other Markers
Cancers · 18.06.2024 · 16 (12) · 2261
DOI: 10.3390/cancers16122261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.06.2024. Verfasst von Johanna Nicklasson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Faculty of Medicine, Lund University, 22100 Lund, Sweden. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Novo Nordic Foundation, Flemming Lunds Foundation, Aase and Ejnar Danielsens Foundation.
Abstract (Originalsprache)
Background
The postoperative complication rate is 30–64% among patients undergoing muscle-invasive and recurrent high-risk non-muscle-invasive bladder cancer surgery. Preoperative risky alcohol use increases the risk. The aim was to evaluate the accuracy of markers for identifying preoperative risky alcohol.
Methods
Diagnostic test sub-study of a randomized controlled trial (STOP-OP trial), based on a cohort of 94 patients scheduled for major bladder cancer surgery. Identification of risky alcohol use using Timeline Follow Back interviews (TLFB) were compared to the AUDIT–C questionnaire and three biomarkers: carbohydrate-deficient transferrin in plasma (P–CDT), phosphatidyl-ethanol in blood (B–PEth), and ethyl glucuronide in urine (U–EtG).
Results
The correlation between TLFB and AUDIT–C was strong (ρ = 0.75), while it was moderate between TLFB and the biomarkers (ρ = 0.55–0.65). Overall, sensitivity ranged from 56 to 82% and specificity from 38 to 100%. B–PEth showed the lowest sensitivity at 56%, but the highest specificity of 100%. All tests had high positive predictive values (79–100%), but low negative predictive values (42–55%).
Conclusions
Despite high positive predictive values, negative predictive values were weak compared to TLFB. For now, TLFB interviews seem preferable for preoperative identification of risky alcohol use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, Faculty of Medicine, Lund University, 22100 Lund, Sweden.
- WHO Collaborating Centre for Evidence-Based Clinical Health Promotion, The Parker Institute, Bispebjerg-Frederiksberg Hospital, University of Copenhagen, 2000 Copenhagen, Denmark.
- Department of Surgery, Herlev-Gentofte Hospital, University of Copenhagen, 2730 Herlev, Denmark.
- Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.
- National Institute of Public Health, University of Southern Denmark, 1455 Copenhagen, Denmark.
ORCID-Profile: Johanna Nicklasson, Hanne Tønnesen, Susanne Vahr Lauridsen, Mette Rasmussen
Förderung
- The Novo Nordic Foundation
- Flemming Lunds Foundation
- Aase and Ejnar Danielsens Foundation
- The Danish Bladder Cancer Group (DaBlaCa)
- Medac and Löf (Landstingens Ömsesidiga Försäkringsbolag) in Sweden
- The Oak Foundation
Zitieren
APA
Nicklasson, J., Sjödell, M., Tønnesen, H., Lauridsen, S. V., & Rasmussen, M. (2024). Identification of Alcohol Use Prior to Major Cancer Surgery: Timeline Follow Back Interview Compared to Four Other Markers. Cancers, 16(12), 2261. https://doi.org/10.3390/cancers16122261
Vancouver
Nicklasson J, Sjödell M, Tønnesen H, Lauridsen SV, Rasmussen M. Identification of Alcohol Use Prior to Major Cancer Surgery: Timeline Follow Back Interview Compared to Four Other Markers. Cancers. 2024;16(12):2261. doi:10.3390/cancers16122261
BibTeX
@article{Nicklasson2024,
author = {Nicklasson, Johanna and Sjödell, Moa and Tønnesen, Hanne and Lauridsen, Susanne Vahr and Rasmussen, Mette},
title = {Identification of Alcohol Use Prior to Major Cancer Surgery: Timeline Follow Back Interview Compared to Four Other Markers},
journal = {Cancers},
year = {2024},
volume = {16},
number = {12},
pages = {2261},
doi = {10.3390/cancers16122261}
}
EUVIMED